Rare lephants
Screener

DocGo Inc.

DCGO ·Healthcare, Medical Care Facilities, United States
Analysis › Company Overview

Business Overview: DocGo Inc. (Nasdaq: DCGO)

Executive Summary

DocGo Inc. is a technology-enabled, mobile health and medical transportation services company operating across all 50 U.S. states and the United Kingdom, positioning itself around "proactive healthcare" that brings clinicians, diagnostics, and transport directly to patients rather than requiring patients to come to a facility. The company runs two interlocking service lines: Mobile Health Services, which pairs on-site clinicians (nurses, LPNs, paramedics) with virtual Advanced Practice Providers to deliver in-home and in-workplace care, and Transportation Services, operated under the Ambulnz brand, which provides non-emergency and emergency medical transportation with a fleet of 582 U.S. and 288 U.K. vehicles. As of December 31, 2025, DocGo employed nearly 3,600 people, including over 900 medical clinicians, and served approximately 1.45 million assigned patients across seven health-insurance payor relationships, while its Transportation segment logged over 11 million miles and 1.3 million patient interactions during the year.

The single most important fact for an investor to understand is DocGo's rapidly shifting revenue mix away from pandemic/migrant-era government work: government contracts fell to 48% of 2025 revenue from 72–73% in prior years, primarily due to the wind-down of New York City migrant-services work, while Mobile Health Services grew to 38% of revenue (Transportation, 62%). This transition — from a company whose growth was substantially driven by one-time emergency government contracting to one trying to build a durable, payor- and health-system-funded mobile care business — is the central thesis an investor must underwrite.

1. Core Business Model & How They Work

DocGo's model is built on dispatching a distributed, technology-coordinated workforce of clinicians and vehicles to wherever care is needed — a patient's home, a workplace, a shelter, or between hospitals/clinics — rather than operating fixed brick-and-mortar sites. On the Mobile Health side, the company combines in-person clinical staff with telehealth-enabled Advanced Practice Providers so that a smaller pool of higher-cost providers (physicians, nurse practitioners) can "see" many more patients virtually while lower-cost field staff handle hands-on tasks (vitals, specimen collection, basic procedures). This hub-and-spoke staffing model is the core unit economics lever: DocGo can scale patient volume without linearly scaling its most expensive labor cost.

On the Transportation side (Ambulnz), DocGo integrates proprietary dispatch and routing technology with major electronic medical record (EMR) systems used by hospitals, enabling it to win recurring inter-facility and non-emergency transport contracts from health systems that want a single, data-integrated transportation vendor rather than a fragmented list of local ambulance companies. The company has grown both segments historically through M&A — in 2025 it acquired a 50-state virtual care network and a mobile phlebotomy provider, continuing a 2022–2025 pattern of acquisitions that expanded geographic coverage and service-line breadth.

Key Operational Drivers

  1. Hub-and-Spoke Clinical Staffing Leverage — virtual Advanced Practice Providers extend the reach of a limited pool of licensed prescribers across a much larger on-site field workforce (900+ clinicians), driving patient-volume scalability without proportional increases in the highest-cost labor.
  2. Shift from Government Emergency Work to Payor-Funded Recurring Care — government contract revenue declining from ~72-73% to 48% of revenue reflects both the loss of one-time NYC migrant-services work and a deliberate strategic pivot toward health-insurance-payor relationships (seven payors, 1.45 million assigned patients) intended to be more durable.
  3. Technology-Integrated Transportation Dispatch — proprietary routing/dispatch software integrated with hospital EMR systems differentiates Ambulnz from local, non-integrated ambulance operators when competing for health-system transportation contracts.
  4. Acquisitive Growth Strategy — repeated bolt-on acquisitions (virtual care networks, mobile phlebotomy, ambulance operators) have been the primary mechanism for entering new geographies and adding adjacent capabilities rather than purely organic buildout.
  5. Dual Fleet Scale (U.S. and U.K.) — 582 U.S. and 288 U.K. vehicles give DocGo cross-border scale in medical transport, with claimed prevention of 91,000 unnecessary emergency-room visits since inception underscoring the value proposition to payors trying to manage total cost of care.

2. Business Segments

Mobile Health Services (38% of 2025 revenue): In-home, in-workplace, and virtual-plus-field clinical care, including diagnostics, treatment, and preventive services delivered by a combination of on-site clinicians and virtual Advanced Practice Providers, serving health plans, employers, and government/community health programs.

Transportation Services (62% of 2025 revenue): Operating as Ambulnz, this segment provides medical transportation (non-emergency and emergency) between clinical settings — hospitals, dialysis centers, skilled nursing facilities — for health systems and payors, using a combined U.S./U.K. fleet with proprietary dispatch technology.

3. Product Portfolio

  • Mobile clinical visits — in-home and workplace diagnostics, treatment, and preventive-care visits delivered by field clinicians.
  • Virtual care network — telehealth-enabled Advanced Practice Provider coverage, expanded via a 2025 acquisition to all 50 states.
  • Mobile phlebotomy — at-home specimen collection, added via 2025 acquisition.
  • Ambulnz medical transportation — non-emergency and emergency ground transport with EMR-integrated dispatch.
  • Government/community health program services — historically including large-scale public health deployments (e.g., NYC migrant services, COVID-era testing/vaccination), now a shrinking share of the mix.

4. Competitive Landscape

DocGo competes against a varied set of players depending on the service line. In mobile/in-home health and virtual care, named competitors include DispatchHealth (direct in-home urgent and primary care), Modivcare (non-emergency medical transportation and care coordination, DocGo's closest direct overlap), Option Care Health (home infusion/specialty care), and large telehealth platforms Teladoc and Amwell. The competitive landscape is also being reshaped by large technology and retail health entrants — Amazon (via Amazon Clinic/One Medical) and CVS Health — that are acquiring their way into home and virtual care with far larger balance sheets and existing consumer relationships. In medical transportation specifically, DocGo/Ambulnz competes with numerous regional and local private ambulance operators as well as Modivcare's brokered non-emergency transportation network.

5. Strategic Strengths & Risks

Strengths: large, multi-state/multi-country operating footprint already built out; demonstrated ability to win and execute large government contracts at scale; growing, more diversified payor book (seven payors, 1.45 million assigned patients) reducing reliance on any single government relationship; integrated technology stack linking dispatch, EMR, and virtual care; track record of accretive bolt-on M&A expanding service lines.

Risks: the sharp decline in government contract revenue (from ~72-73% to 48%) shows the business's historical growth was substantially reliant on episodic public-health/emergency contracting that is now gone, and replacing that revenue with payor-funded recurring care is unproven at the same scale; the company has faced public scrutiny and legal/regulatory questions tied to its NYC migrant-services contracts, which carries reputational and legal risk; competition from much larger, better-capitalized entrants (Amazon, CVS) raises long-term pricing and account-retention risk; labor-intensive clinical staffing model exposes margins to wage inflation and clinician availability constraints; integration risk from a steady cadence of acquisitions.

6. Financial Overview

DocGo's 2025 revenue mix shows Transportation Services contributing 62% and Mobile Health Services 38% of total revenue, with government contracts representing 48% of total revenue (down sharply from 72-73% previously) as NYC migrant-services work wound down. The company's scale metrics — nearly 3,600 total employees (2,905 of them healthcare professionals, 129 field managers, 534 corporate staff), 11+ million transportation miles, and 1.3 million patient interactions in 2025 — indicate a business of meaningful operating scale even as its revenue mix has shifted. Major customers/partners named in the filing include NYC Health + Hospitals, the Department of Veterans Affairs, and the Indian Health Service, alongside the seven commercial/managed-care payors feeding its Mobile Health patient base.

7. Summary Conclusion

DocGo occupies a genuinely useful niche at the intersection of mobile clinical care and medical transportation, with real scale (fleet size, clinician headcount, patient volumes) and technology integration that differentiate it from fragmented local competitors. However, the company is mid-transition from a business whose historical growth leaned heavily on large, sometimes controversial, government emergency contracts toward one trying to prove it can sustain similar scale through payor-funded recurring mobile health services. The moat, such as it is, rests on contract switching costs and dispatch/EMR integration rather than any structural barrier to entry, and the next several years of payor-mix execution — not the past several years of government-contract growth — will determine whether DocGo becomes a durable healthcare-services platform or a shrinking former pandemic-era beneficiary.